2008-08
2012-05
2012-05
156
NCT00918853
Institut Paoli-Calmettes
Institut Paoli-Calmettes
INTERVENTIONAL
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas
This multicentric prospective study evaluates the role of the margins resection and the ganglionic status when using a quality standard for the resection of adenocarcinoma of the head of the pancreas.
Primary objective: * Evaluation of the prognosis role of the invasion of the margins on the overall survival after a standard resection of adenocarcinoma of the head of the pancreas. Secondary objectives: * Evaluation of the prognosis role of the invasion: * Of margins on the overall survival. * Of each margins (distal pancreatic margin, gastric, posterior, retro-venous, retro-arterial) on the overall survival. * Of the ganglionic group of the superior mesenteric artery and the other nodes.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates | Results Reporting Dates | Study Record Updates |
---|---|---|
2009-06-09 | N/A | 2015-03-19 |
2009-06-10 | N/A | 2015-03-20 |
2009-06-11 | N/A | 2013-03 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Treatment
Allocation:
Na
Interventional Model:
Single Group
Masking:
None
Arms and Interventions
Participant Group/Arm | Intervention/Treatment |
---|---|
EXPERIMENTAL: resection for adenocarcinoma quality standard resection for adenocarcinoma of the head of the pancreas | PROCEDURE: resection of adenocarcinoma of the head of the pancreas
|
Primary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Prognostic value of the invasion of the margins measured in millimetres on the overall survival | 4 years |
Secondary Outcome Measures | Measure Description | Time Frame |
---|---|---|
Relapse free survival: time between surgery and relapse or a right censure. The relapse is determined by clinical examination, biologic examination and imaging, which reveals metastasis or an isolated local relapse | 4 years |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.